04/09/2026
Today marks a significant milestone in Actio Pharm’s journey with the official launch of NaCl 1000 MG—a valuable addition to our portfolio that reflects our commitment to delivering reliable pharmaceutical solutions that address specific therapeutic needs.
NaCl 1000 MG is formulated to support the management of hyponatremia associated with various clinical conditions, including diuretic-induced hyponatremia, Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH), Addison’s disease, and cerebral or renal salt-wasting syndromes.
With this launch, we reaffirm our dedication to providing trusted and effective healthcare solutions that support healthcare professionals and contribute to improved patient care.
NaCl 1000 MG — Advancing solutions in sodium deficiency management.